The investigators aimed to investigate the clinical and epidemiological characteristics of neonates who will be born to Covid-19 positive mothers in Turkey. It is a multicentric prospective cohort study designed and destined only in Turkey. The investigators are planning to admit more than 20 Neonatal Intensive Care Units into the survey; nevertheless, the total number may change according to the prevalence of Covid-19 in neonates. The investigators will also inquire into vertical transmission by collecting cord blood, placental, and postnatal serum samples to test for Covid-19 PCR and Covid-19 Ig M and IgG values from the neonates.
The patients will be recruited by a secure database of "Trials Network" with individualized
accounts. Plexus Corporation will hold data monitoring and primary analysis.
Inclusion Criteria:
- Infants born to mothers with Covid-19 infection
Exclusion Criteria:
- If PCR values of mother negative, even though the clinic is preferable for Covid-19,
the infant will not be recruited.
Recep Tayyip Erdogan University Medical School
Rize, Turkey
Investigator: Mehmet K Kanburoglu, M.D.
Contact: +905326685916
kanburoglumk@outlook.com
Mehmet K Kanburoglu, M.D.
+905326685916
kanburoglumk@outlook.com
Mehmet Y Oncel, M.D.
+90532 631 51 85
dryekta@gmail.com
Mehmet K Kanburoglu, M.D., Study Director
Head of Pediatrics and Neonatology, Associate Professor